Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
NCT00537602
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class
Stopped
Methodology applied did not meet all criteria required per guidelines
Conditions
Cystic Fibrosis
Interventions
DRUG:
miglustat
DRUG:
placebo
Sponsor
Actelion